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Abstract
TGFβ3 signaling initiates and completes sequential phases of cellular differentiation that is required for complete disintegration of the palatal
medial edge seam, that progresses between 14 and 17 embryonic days in the murine system, which is necessary in establishing confluence of the
palatal stroma. Understanding the cellular mechanism of palatal MES disintegration in response to TGFβ3 signaling will result in new approaches to
defining the causes of cleft palate and other facial clefts that may result from failure of seam disintegration. We have isolated MES primary cells to
study the details of MES disintegration mechanism by TGFβ3 during palate development using several biochemical and genetic approaches. Our
results demonstrate a novel mechanism ofMES disintegration whereMES, independently yet sequentially, undergoes cell cycle arrest, cell migration
and apoptosis to generate immaculate palatal confluency during palatogenesis in response to robust TGFβ3 signaling. The results contribute to a
missing fundamental element to our base knowledge of the diverse roles of TGFβ3 in functional and morphological changes that MES undergo
during palatal seam disintegration. We believe that our findings will lead to more effective treatment of facial clefting.
© 2007 Elsevier Inc. All rights reserved.Keywords: Palate; TGFβ; Migration; Apoptosis; MESIntroduction
Cleft palate, the most common craniofacial deformity, is
caused by the failure of palatal midline epithelial seam (MES)
cells to disintegrate, which is necessary for palatal mesenchy-
mal confluence. While transforming growth factor (TGF) β3
plays an important role in a number of model systems, it has
been well established that it plays an essential role in
palatogenesis (Murray and Schutte, 2004), particularly at a
later stage of palatogenesis when the newly formed MES must
undergo disintegration for palatal confluency. We and others
have demonstrated that TGFβ3 regulates the disintegration of
the palatal MES after adhesion of the palatal shelves, and that
becomes part of the palate connective tissue, thus establishing
confluence of the palatal stroma in murine model system
(Kaartinen et al., 1997). Mice null for TGFβ3 are normal in⁎ Corresponding author. Fax: +1 402 472 2551.
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doi:10.1016/j.ydbio.2007.06.018most regard, but are born with cleft palate (Kaartinen et al.,
1995). The cellular mechanism underlying seam degeneration
and the fate of the MES cells have been a major focus of the
field for more than a decade. However, controversies still
remain on this issue. Using several labeling techniques, two
major models have been proposed for seam degeneration:
migration (Hay, 1995; Jin and Ding, 2006; Kaartinen et al.,
1997; Kang and Svoboda, 2005; Lagamba et al., 2005;
Nawshad and Hay, 2003; Pungchanchaikul et al., 2005; Shuler
et al., 1992; Sun et al., 2000b; Takahara et al., 2004; Takigawa
and Shiota, 2004) or apoptosis (Cuervo and Covarrubias, 2004;
Dudas et al., 2006, 2007; Taniguchi et al., 1995; Vaziri Sani et
al., 2005; Xu et al., 2006), while proponents of either hypothesis
do not agree with the alternate hypothesis. However, all are in
agreement that both events are caused by TGFβ3.
The biggest weakness in our understanding of palate
development is the connection between TGFβ3 signaling and
palatal MES cell behavior. While there are several approaches
to this problem, we were able to learn much from simply
assembling a more complete picture of the localization and
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disintegration. By using MES cells in culture, we were able to
develop reliable stages of palatogenesis in MES cell culture
that mimic the in vivo system to interpret TGFβ3 signal in a
greater depth which otherwise was not possible in in vivo
studies.
However, our previous (Nawshad and Hay, 2003; Nawshad
et al., 2004, 2007) results demonstrated that TGFβ3 signaling is
capable of causing cell migration in the MES epithelia.
However, in this study, we show that immediate response of
MES to TGFβ3 induction is to undergo cell cycle arrest prior to
cell migration. At later stages of palatogenesis, TGFβ3 exerts its
effects in MES cell apoptosis to complete palatal confluency;
however, apoptosis is independent of migration. These exciting
data suggest that TGFβ3 provides a novel mechanism for three
different yet chronological phenotypical changes (cell cycle
arrest, cell migration and apoptosis) which are essential for
palatal MES disintegration, and is the first evidence of multiple
roles of TGFβ3 in palatogenesis.
Materials and methods
Culture of isolated primary MES cells
Fifteen (15) timed-pregnant CF1 mice (Charles Rivers Laboratories, Inc.,
Boston, MA) were used for these studies. From our earlier work (Lagamba et al.,
2005; Nawshad and Hay, 2003; Nawshad et al., 2004), we have found that the
CF1 mouse strain weighs (50 g) more than other normal strains and so do their
embryos. The size of the developing palatal shelves is substantially larger which
allows more cells to be collected for protein/RNA and DNA analysis. We
obtained about 8–10 healthy 14-day post coitum (dpc) embryos from each
pregnant mouse. For normal palates, protocols and methods of anesthesia,
surgery, collecting embryos, and dissecting palatal shelves from pregnant mice
have been undertaken by us previously and described in detail in Lagamba et al.
(2005), Nawshad and Hay (2003), and Nawshad et al. (2004). Isolated palates
were cultured at 37 °C in a humidified gas mixture incubator (5% CO2 and 95%
air), and the medium was changed every 24 h. Palatal shelves were processed
with two different treatment regimens: (i) For placing the MES cells in culture,
palatal shelves were processed and treated as described below and mentioned in
further detail in Nawshad et al. (2007). (ii) For organ culture, palatal shelves were
collected as described in Lagamba et al. (2005), Nawshad and Hay (2003), and
Nawshad et al. (2004).
The single cell thick periderm covering on each shelf was removed by
incubating the shelves with Proteinase K for 1 h in 37 °C. The shelves were
then cultured at 37 °C for 12 h to allow brief adherence to the corresponding
opposite shelf (adhered). Adhered shelves in organ culture was then cut close
to the seam to ensure limited or no mesenchymal tissues attached to isolated
seam. The shelves were then separated and treated with Dispase II for 30 min
to allow the primary MES cells to separate from the underlying basement
membrane so that we could collect epithelial cells without any mesenchymal
contamination. Cells were then cultured in flasks and harvested at the
exponential growth stage (∼80% confluence) before any exogenous
treatment began. From one pair of palates, we could isolate enough cells to
seed one T-25 flask. The cells were splitted 1:2 every 3 days as many as 5
times to generate ample MES cells with preservation of healthy growth and
morphology for experiments and storage. Approximately 106 MES cells were
used for each treatment conditions. In vivo, MES cells produce optimum
endogenous TGFβ3; however, when MES cells were removed from primary
tissue, TGFβ3 ceased its usual high expression in vivo to only a mild
expression (Nawshad et al., 2007) as well as (Fig. S1). Such low expression
was not sufficient to induce cellular changes. Since TGFβ3 expression
increases during MES disintegration in vivo (Lagamba et al., 2005) as well as
shown in the supplementary results (Fig. S1), we added exogenous TGFβ3 at
5 ng/mL every 24 h to the MES cells to mimic the in vivo results.Clonal analysis for homogeneity of the MEE cells
Primary MES cells obtained from paired palatal shelves were trypsinized
and single cell, 10 cells, and 100 cells of clonal density were isolated under the
microscope, seeded in triplicate plated onto a regular feeder-layer in separate
gelatin-coated 60-mm Petri dishes containing Dulbecco's Modified Eagle's
medium, DMEM (ATCC, VA) with 10% fetal bovine serum (FBS) (Gibco, CA),
100 U/mL penicillin, and 100 μg/mL streptomycin (Sigma-Aldrich, MO).
Whenever needed, FBS was removed from appropriate experimental conditions.
All cultures were incubated for 3 days in a humidified CO2 incubator at 37 °C in
(5% CO2 and 95% air) and medium was changed every 24 h. Colonies were
monitored microscopically on a daily basis to ensure that they were derived from
single cells. Colonies were counted and the cloning efficiency (CE) was
determined from the formula CE (%)=5 (number of colonies/number of cells
seeded)×100=5 (number of colonies / number of cells seeded)×100. A
representative number of cells contained within the grid were counted from the
center of the colony and also for the edges of the colony, where cells were loosely
packed, and then the number of grids/colony counted and multiplied by cell
number/grid to give a total cell count per colony. Clusters of cells were considered
colonies when they were visible macroscopically and contained greater than 100×
cells from the original number of seeded cells.
After 3 days of cultivation, plates were carefully scored for the presence of a
uniform homogenous colony of epithelial cells under a microscope. Productive
colonies were photographed under a Zeiss Axiovert microscope. We have
observed (by FACArray) that a small percentage (1.2%) of MES cell in culture
dies before reaching 70% confluence. Only those colonies from which
productive clones of 100% live epithelial cells were derived were then
transferred by trypsinization to two indicator dishes. One dish was used for
serial propagation and further analysis. The second dish was fixed with Buin's
fixative for 10 min after a PBS wash for the assessment of cobblestone epithelial
morphology and stained with E-cadherin, Desmoplakin, and Desmoglein for
classification of epithelial clone type.
Treatment conditions
Only necessary induction or inhibition was carried out with appropriate doses
and untreated MES cells were used as the control. The concentration of each
inhibitor or activator has already been optimized to minimize the toxicity for
MES cells in previous studies (Lagamba et al., 2005; Nawshad and Hay, 2003;
Nawshad et al., 2004). Additional treatment conditions are included later in
appropriate sections. zVAD-fmk (20 μM) was obtained from Sigma-Aldrich
(MO); GFP-retrovirus encoding full-length E-cadherin cDNA was kindly
provided by Prof. Keith R. Johnson, UNMC, NE and empty GFP-retrovirus
vector was kindly provided by Dr. Jim Wahl, UNMC, NE.
Immunofluoroscene and immunoblot
As described earlier in Nawshad et al. (2007). Antibodies were obtained
from the following sources: E-cadherin (kindly provided by Dr. James Wahl,
UNMC, NE); Vimentin (Zymed, CA); α-SMA (Sigma-Aldrich, MO); BCL-2,
Bax, c-Myc, β-Actin, and Fibronectin (Abcam, MA); apoptotic inducing factor
(AIF), p15, p21, p27, caspase 3, caspase 9, cleaved caspase 3, and PCNA (Cell
Signaling Technology, MA); TGFβ3 (R&D Systems, CA); affinity purified
Cy3, Cy5, fluoroscene-, and rhodamine-conjugated secondary Antibody
(Invitrogen, CA).
Scratch wound assay
As shown earlier in Nawshad et al. (2007). Briefly, MES cells were grown to
100% confluence in six-well culture plates that underwent straight line-shaped
scratch by scraping with a sterile pipette tip to uniformly wound the cells. Both
treated and untreated wounded cultures were examined for 72 h. Themigration of
cells (or gap filling) was observed every 12 h through phase-contrast microscopy
where cells were morphologically assessed for the migratory phenotype. The
center of the scratch line was used for positioning.
Transwell cell migration assay
As demonstrated earlier in Nawshad et al. (2007) using the Innocyte™ Cell
Migration Assay (EMD Biosciences, CA). Briefly, 8 μm pore size transwell
migration chambers in 96-well plates were used for migration analyses. Both
treated and untreated MES cells were allowed to migrate across the membrane
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(chemotactic migration). Cells that migrate through the membrane and attach to
the lower side of the cell culture insert were subsequently detached using cell
detachment buffer containing Calcein-AM fluorescent dye (excitation max.:
485 nm; emission max.: 520 nm). The data were obtained using BD Bio-
analyzer™ fluorescent plate reader (BD Biosciences, CA).
Cell cycle analysis
MES cells were grown in 10% FBS containing DMEM in T-25 flasks.
Approximately 60% confluent cells were treated with 6.0 μM Aphidicholin
(Sigma-Aldrich, MO) for 16 h, washed with Hanks Buffered Saline Solution
(HBSS) (Mediatech, VA), and released into complete medium for 30 min. Cells
were then treated with complete medium containing TGFβ3 (5 ng/mL) for 72 h
changing every 24 h. Cells were collected every 12 h for cell cycle analysis byBD
FACSArray Bioanalyzer (BD Biosciences, CA). Cells were detached by trypsin
and collected in 15 mL tube after washing with 1× PBS. Then cells were fixed by
adding ice-cold 70% ethanol drop by drop while slowly vortexing and incubated
for 24 h at −20 °C. Fixed cells were then washed once with 1× PBS and adjusted
the cell concentration to 4×105 and stained with 1 mg/mL of Propidium Iodide
(PI) and RNase (Sigma-Aldrich, MO) for 30 min at room temperature. These PI
stained cells were then analyzed by BD FACSArray Bioanalyzer using green
laser at 532 nm wavelength.
Live and dead cell staining
MES cells were grown in 10% FBS containing DMEM in T-25 flasks.
Approximately 60% confluent cells were treated with 6.0 μM Aphidicholin for
16 h, washed with HBSS and released into complete medium for 30 min. Cells
were then treated with complete medium containing 5 ng/mL of TGFβ3 for 72 h.
Cells were collected every 24 h for live and dead cell stain analysis by BD
FACSArray Bioanalyzer. Vibrant cell metabolic assay kit and Sytox red dead cell
stain were purchased from Invitrogen. Cells were stained according to
manufacturer's protocol. In brief, first, the floating cells were collected by spin
down. Fourmicroliters of 1× PBSwas added to the flask and 1mL of 1× PBSwas
added to dissolve the collected floating cells and then added this dissolved pellet
to the flasks. Then 2 μMconcentration of C12-resazurin was added to those flasks
and incubated for 15 min in 37 °C. After this, cells were detached by trypsin and
collected, dissolved the pellet in 5 nM Sytox Red stain/mL of 1× PBS, and
incubated for a minimum 15min at room temperature in dark. These stained cells
were analyzed by BD FACSArray Bioanalyzer using green laser at 532 nm
wavelength and red laser at 635 nm wavelength for C12-resazurin and Sytox Red
stain, respectively.
Apoptosis assays
(a) Detection of LMW DNA fragments: Nuclear DNA underwent conven-
tional 1.5% agarose gel electrophoresis to show any oligo DNA fragments.
Briefly, 1 mL of lysis buffer from DNA extraction mixed with 1 mL of ethanol
was kept at −20 °C for 18 h and then centrifuged. The pellet was rinsed with 70%
ethanol, centrifuged again, and the final DNA pellet was diluted in 20 μL of
10 mM Tris, pH 8, 1 mM EDTA, and 10 μg/mL RNase. Conventional 1.5%
agarose-gel electrophoresis was performed. Gels were stained with SYBR Safe
(Molecular Probes); (b) DNA fragmentation and integrity Assay by Pulsed-field
gel electrophoresis: MES cells were grown in DMEM containing 10% FBS and
1% penicillin/streptomycin. The cells were incubated at 37 °C in a humidified
atmosphere of 5% CO2 until 60–70% confluence was reached.
We used CHEF Mammalian Genomic DNA plug Kit (BioRad, CA), that
included all reagents and buffers, to undertake this experiment. A λ DNA–
HindIII PFGE marker was purchased from and New England Biolab (MA).
DNA plugs were prepared according to manufacturer's protocol. Briefly, an
aliquot of 0.2×106 cells/mLwas treatedwith 5 ng/mL of TGFβ3 for 72 h andwas
collected every 12 h. Cells were washed by centrifugation (1000×g, 5 min, 4 °C)
and mixed with 2% CleanCut agarose (Bio-Rad, CA) to a final concentration of
0.75% at 50 °C. The cells/agarose mixture was transferred to plug molds and
solidified on ice. Agarose plugs were lysed with Proteinase K in reaction buffer
and were incubated overnight at 50 °C.
Thereafter, plugs were washed four times in a 1× wash buffer and stored at
4 °C in this buffer. Washed plugs were inserted into the wells of a 1% agarose gel
prepared in 0.5× TBE buffer. The gel was run using CHEF DRIII (Bio-Rad)
apparatus set to the following protocol: run time, 14 h; switch time from 5 to50 s; voltage gradient, 6 V/cm. After electrophoresis, the gel was stained with
0.5 μg/mL ethidium bromide and examined under UV light. (c) TUNEL assay:
To clarify the spatial distribution of DNA fragmentation, we performed TUNEL
which employs TdT to add dUTP to the fragmented DNA ends. We used
TUNEL Apoptosis Detection kit (Millipore, MA). (d) Detection of AIF protein
expression: As described by Frankfurt and Krishan (2001), briefly MES cells
were fixed in methanol–PBS (6:1) for 48 h. Fixed cells were re-suspended in
0.25 mL of formamide (5×105 cells in 15-mL plastic tubes) and cells were
washed with 2 mL of 1% non-fat dry milk in PBS, incubated with monoclonal
antibody against AIF for 2 hours at RT. Cells were then rinsed with PBS and
stained with fluorescein-conjugated anti-mouse IgM (1:50 in PBS containing 1%
non-fat dry milk) for 1 h at RT and preparations of antibody-stained cells were
counterstained in PBS for 10 min.
Results
Using primary cultures derived from palatal MES cells iso-
lated from 14 dpc mouse embryos, we showed that TGFβ3
signaling chronologically orchestrates highly synchronized
phenotypical changes to bring about successful palatal con-
fluency during palatogenesis. TGFβ3 induces cell cycle arrest,
represses cell–cell adhesion to activate MES cell disintegration
by migration, and then induces apoptosis of MES cells during
palate development. We identified key regulatory molecules in
the TGFβ3 signaling pathways that induce cell cycle arrest,
migration, and apoptosis in a time-dependent fashion. We,
however, do not know the mechanisms of activation of exact
pathways that TGFβ3 employs to elicit these three morpholo-
gical changes needed for successful MES cell disintegration.
Our results are described in the following subheadings
describing each figure chronologically:
Stages of palatal MES disintegration and the role of apoptosis
in MES disintegration
First we established that whole palates from 14 dpc
embryonic mice undergo MES disintegration in response to
exogenous TGFβ3 when removed and placed in organ culture.
The results showed that the newly formed intact seam at 12 h
(Fig. 1A, white arrow) gradually disintegrate in 24 and 48 h
(Figs. 1B, C) and eventually disintegrate completely to form
confluent palates by 72 h (Fig. 1D, blue arrow). These stages
(Figs. 1A–D) were similar to those seen in vivo. Palates treated
with anti-TGFβ3 blocking antibody, formed a seam, but the
MES did not undergo disintegration (Fig. 1E, white arrows). To
demonstrate the necessity of apoptosis in MES disintegration,
we blocked apoptosis by treating the palatal shelves with pan
caspase inhibitor, zVAD-fmk, which had a late effect, and caused
incomplete MES disintegration (Fig. 1F, inset, white arrow).
These results demonstrate the importance of TGFβ3 in palatal
confluency and suggest that apoptosis does take place late for the
completion of MES disintegration.
Epithelial cells derived from single clone of MES cells
Before we undertook any experiment, we first confirmed
that MES collected from 14 dpc CF1 embryos is a pure clone
of epithelial cells and devoid of any mesenchymal contamina-
tion. Using Dispase II, we were able to dissect only the MES
Fig. 1. Stages of normal palate development. Single palatal shelves collected
from 14 dpc CF1 mouse embryos were placed together with the corresponding
opposite palatal shelf and incubated in organ culture in the presence of
exogenous recombinant TGFβ3 (5 ng/mL) for up to 72 h (added every 24 h).
They were collected at 12, 24, 36, 48, 60, and 72 h of culture and stained with
hematoxylin and eosin (H&E). Palatal shelves adhered to form the MES by 12 h
(A, white arrow). At 24 h, the seam began to separate into small islands of
epithelial cells (B). By 48 h, a few MES cells remained (C). By 72 h, the seam
completely disintegrated and palatal confluency was complete (D, blue arrow).
However, when the single palatal shelves were treated with TGFβ3-blocking
antibody (5 ng/mL), seam remained intact as late as 72 h (E, white arrow), and
when apoptosis was blocked with pan caspase inhibitor, zVAD-fmk (20 μM),
remnants of the MES cells were still present at the oro-palatine and naso-palatine
triangle and fusion was incomplete (F, white arrow). Single palates were treated
with the inhibitors for 24 h to have their effect before the shelves were placed
together to form a seam. Each scale bar value, as stated, represents the size and
magnification of the image.
Fig. 2. Collection of primary MES cell: palate medial edge epithelial cells from
CF-1 mouse (Charles River Laboratories) embryos were separated from
underlying mesenchyme using Dispase II (Roche), from palatal shelves adhered
for 12 h in organ culture, as previously described in Nawshad et al. (2007) (A).
Cells were then cultured into primary cell lines in DMEM+10% and FBS+1%
penicillin/streptomycin (B). Following confirmation of the clonal homogeneity
of the MES epithelial cells (see Materials and methods for detail) and that they
derive from single clone devoid of any mesenchymal contamination, MES cells
were stained for the expression of epithelial markers such as E-cadherin (C,
arrow), Desmoplakin (D, arrow), and Desmoglein (E, arrow) to demonstrate that
isolated cells maintained fully and only epithelial characteristics. Cells were
treated with exogenous recombinant TGFβ3 (5 ng/mL) every 24 h and all
experiments were performed in triplicate. Each scale bar value, as stated,
represents the size and magnification of the image.
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the intact mesenchyme, only the epithelial cells slough-off
(Fig. 2A) with no effect on the mesenchyme. We then collected
1, 10, and 100 cells (Fig. 2B) and by employing clonal
homogeneity experiments (see Materials and methods), we
were able to culture pure homogenous population of MES
only. We confirmed that these clone of MES cells have all
epithelial characteristics by demonstrating increased expression
of E-cadherin (Fig. 2C), Desmoplakin (Fig. 2D), and
Desmoglein (Fig. 2E).TGFβ3 sequentially activates cell migration and then apoptosis
To study the chronological events of phenotypical changes
that MES undergo in response to TGFβ3 in cell culture
condition, we treated the 80% confluent MES cell with
recombinant exogenous TGFβ3 (5 ng/mL) and monitored its
changes under phase contrast microscope. We found that after
48 h of TGFβ3 treatment, MES cells in culture became motile
(Fig. 3B), but at 60 h, cells began to die and apoptotic bodies
were seen (Fig. 3C, arrow). At 72 h, the numbers of apoptotic
cells continued to increase (Fig. 3D, arrow). When apoptosis
was blocked by zVAD-fmk, MES cells maintained a migratory
phenotype like that seen in Fig. 3B, showing that apoptosis was
not involved in cell migration (Figs. 3E–H). When TGFβ3
signaling was blocked after MES cells have converted to a
migratory phenotype (Fig. 3J), MES cells did not revert back to
Fig. 3. TGFβ3 induces MES migration followed by apoptosis: 80% confluent MES cells were treated with TGFβ3 (5 ng/mL) every 24 h for 72 h. MES cells showed
gradual phenotypical changes from adhered epithelial (A) to fully motile and migratory fibroblastoid at 48 h (B) but began to die at 60 h (black arrow) as apoptotic
bodies began to appear (C) and apoptosis continued to increase at 72 h (D). When apoptosis was blocked with zVAD-fmk, MES cells continued to migrate (E–H). In
the presence of TGFβ3, MES cells underwent migratory changes (J), and the cells remained migratory even after TGFβ3 signaling was blocked with blocking TGFβ3
antibody (K, L). Scale bar value (50 μm) represents the size and magnification of the image.
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indicating that TGFβ3-induced migratory MES cells require
continuous TGFβ3 to undergo apoptosis These results suggest
that migration and apoptosis in the MES cells are results of
TGFβ3 signaling and that they are sequential but independent
events.
TGFβ3 down-regulates E-cadherin in cultured MES cells
We investigated the expression of E-cadherin as MES cells
progress through different phases of cellular changes in response
to TGFβ3. We demonstrated that cultured MES cells expressed
high levels of E-cadherin, remained epitheloid, and maintained
strong cell–cell adhesion (Fig. 4A). When treated with
exogenous TGFβ3 (5 ng/mL), MES cells showed a significant
reduction in E-cadherin protein expression within 24 h (Fig.
4B). In addition, at 48 h, motile MES cells expressed proteins
such as Fibronectin (Fig. 4C), Vimentin (Fig. 4D), and α-
Smooth Muscle Actin (SMA) (Fig. 4F), which are typical of
migratory cells. These results demonstrate that repression of E-
cadherin protein expression is an early event and once cell–cell
adhesion is lost, MES cells become motile and express
migratory proteins.
Repression of E-cadherin is necessary for cell migration
To examine the importance of E-cadherin repression for
cell migration, we retrovirally infected the confluent MES
cells with a full length E-cadherin cDNA-GFP to maintainincreased E-cadherin expression (Figs. 5A, C) or a control
GFP viral construct without E-cadherin (Figs. 5B, D). MES
cells maintain high level of E-cadherin. We investigated the
effect of TGFβ3 on the migration of cultured MES cell using
the Scratch wound assay. MES cells expression high E-
cadherin did not show any motility in the Scratch wound
assay (Figs. 5E, G) and migration (Fig. 5L) in the presence of
TGBβ3. Control MES cells treated with the empty GFP
vector showed the usual motility in the presence of TGBβ3
(Figs. 5F, H).
In culture, once MES cells repressed E-cadherin in response
to TGFβ3 (as shown in Fig. 4B), they became motile and
migrated to close the wound within 48 h (Fig. 5J), compared to
control untreated MES cells (Fig. 5I). Blocking apoptosis with
zVAD-fmk did not prevent cell migration (Fig. 5K). Transwell
MES cell migration (Fig. 5L) assay also supported these
findings of Scratch wound assay (Figs. 5E–K) showing that in
response to TGFβ3, MES cells migrated in culture and the
motility was dependent on TGFβ3. And apoptosis was an
independent mechanism (Figs. 5K, L). These results support
the notion that repression of E-cadherin facilitates MES
migration and that cell migration and apoptosis are not
dependent.
TGFβ3 induces cell cycle arrest
As TGFβ is a potent inducer of cell cycle arrest, we
investigated if TGFβ3 causes cell cycle arrest in the MES
cells. Here we showed that MES cells underwent cell cycle
Fig. 4. E-cadherin is reduced in response to TGFβ3. MES cells were grown to
80% confluence as described in Fig. 3. Untreated MES showed membrane
localization of E-cadherin (A). E-cadherin was significantly reduced when the
cells were treated with TGFβ3 for 24 h (B). MES cells were stained with
fluorescence (A, B) conjugated antibody against E-cadherin and counterstained
with DAPI. At 48 h, when MES cells become migratory as a result of reduced
cell–cell adhesion E-cadherin, migratory MES cells expressed Fibronectin (C,
Alexa Fluor 488), Vimentin (D, Alexa Fluor 594), and α-SMA (F, Alexa Fluor
350) (merged all proteins in panel E). Each scale bar value, as stated, represents
the size and magnification of the image.
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migration and apoptosis. All MES cells were synchronized to
G1 phase (with Aphidicolin 6.0 μM). G1 phase-synchronized
MES cells showed cessation of the cell cycle almost
immediately in response to TGFβ3 signaling and showed
that nearly all (98%) MES cells remain at the G1 state (Fig.
6A). TGFβ3 completely halted MES cell progression through
next phases of the cell cycle. At no point did MES cells
advance to the next (S, G2, M) phases of the cell cycle (Figs.
6A–F). As MES cells failed to progress through cell cycle,
later MES cells began to die with 2.38% dead cell by 48 h
(Fig. 6D) and this percentage increased to 23.33% by 72 h
(Fig. 6F). However, TGFβ3 untreated control MES cells
showed successful progression through all phases of cell
cycle (Figs. 6G–L).
Apoptosis is an integral but late event in MES cells
Next we examined, in addition to cell migration (as shown
in Figs. 3–5) and cell cycle arrest (Fig. 6) whether TGFβ3also regulates MES cell death (Fig. 7). We investigated the
status and timing of the induction of apoptosis in response to
TGFβ3. We demonstrated that MES cells treated with TGFβ3
showed the first evidence of apoptosis after 60 h in culture,
following cell migration (as shown in Fig. 3C). The time
course of apoptosis was more accurately shown by FACSAr-
ray analysis with the incorporation of Sytox red (dead cells)
and C12-resazurin (live cells). In the beginning (0 h) of the
MES in culture, majority (98.5%) of the cells were live and
viable as shown by green spots (P2). Within 12 h of TGFβ3
treatment, even as some of the MES cells continued to grow
(P2), 22% MES cell ceased to proliferate and undergo cell
cycle arrest (Pink, P4). With ongoing TGFβ3 treatment, MES
cells continued to increased the number of cells that under-
went cell cycle arrest (P4 at 24, 48, and 60 h). However, a
small percentage (11%) of MES cells were apoptotic (Red, P1)
by 60 h, while most of the cells (83%) were still under cell
cycle arrest.
By 72 h, a significant fraction (∼33%) of the MES cells
were dead (P1) with very little debris (blue, P3). In control,
untreated MES cells at 72 h, cells were mostly (95%) live (P2)
with only 4.8% non-proliferating (P4), 3% apoptotic (P1), and
1% debris (P3). These FACSArray studies allowed us to
identify not only the cell proliferation and apoptosis but also
the precise percentage of cells undergoing these changes,
which otherwise is not feasible in in vivo or in organ culture
conditions.
In vivo, apoptosis is also a late phenomenon during MES
disintegration
To investigate whether the late induction of apoptosis
shown by FACArray (Figs. 6 and 7) is compatible in vivo, we
showed a similar late apoptotic event in the presence of
TUNEL positive cells in developing palate. At 17 dpc, a few
remaining MES cells were TUNEL positive (white arrow, Fig.
8A, fluorescent labeled and black arrow, Fig. 8B, avidin–
biotin labeled) at the oral and nasal triangular regions of the
developing palate. We also tested for apoptotic cells in MES
cells in culture, and found that at 72 h post TGFβ3
treatment, MES cells showed TUNEL positive cells (Fig.
8D, arrow) but untreated cells were not TUNEL positive
(Fig. 8C). In accord with results from Figs. 6 and 7, results
in Fig. 8 demonstrated that apoptosis was a late event in
MES cell disintegration both in vitro and in vivo.
Cell cycle arrest and apoptotic markers are induced by TGFβ3
We next studied the expression of established markers of
cell cycle arrest and apoptosis in the MES cells. We found
that MES cells expressed increased amounts of cell cycle
arrest proteins p15, p21, and p27 in a time-dependent manner
from 12 to 72 h in response to TGFβ3 (H). In contrast, the
cell proliferation marker, PCNA, was not detected (Fig. 9A).
Caspases 9 and 3, protein inducers of apoptosis, were
expressed but increased at 36 h and had high expression at
72 h (Fig. 9B). Activation of caspase 3 requires proteolytic
Fig. 5. MES cells with increased E-cadherin do not migrate. Confluent MES cells were transiently infected with GFP-retrovirus encoding full-length E-cadherin cDNA
as well as control GFP without the E-cadherin cDNA (A, B). Infection rate was high (C, D) for both the constructs. Transduced MES cells expressed GFP within 48 h.
We used Scratch wound assays (G, H, and I–K) to morphologically assess the migratory phenotype and evaluate the cell motility. MES cells were treated with TGFβ3
(5 ng/mL). After 48 h, only the GFP-control cells were motile and migrated into the gap (F, H—phase contrast). But MES cells expressing high E-cadherin failed to
migrate and remained epithelial (E, G—phase contrast). TGFβ3 promotes cell migration and motility independent of apoptosis: our results also showed lack of cell
migration in untreated (control) MES cells (I). MES cells treated with TGFβ3 (5 ng/mL) become motile (J). Blocking apoptosis with zVAD-fmk, had no significant
role in MES cell migration and motility (L, K) (mean±SD; n=3; pb0.05; RFU—Relative Fluorescence Unit). Transwell cell migration assay results were compared
with Scratch wound assay and were found to be in accord as cell migration was also induced upon TGFβ3 and transiently infected with GFP-retrovirus encoding full
length E-cadherin cDNA that can inhibit cell migration, whereas inhibiting apoptosis with zVAD-fmk has limited or no effect on migration (L). Each scale bar value, as
stated, represents the size and magnification of the image.
199S. Ahmed et al. / Developmental Biology 309 (2007) 193–207processing of its inactive zymogen into fragments resulting
from cleavage adjacent to Asp175. Caspase 3 was cleaved
(Asp175) into 17 and 19 kDa fragments in response to
TGFβ3 and showed a higher expression at 60 and 72 h (Fig.
9C). Anti-apoptotic BCL-2 was expressed early but graduallydecreased from 12 to 72 h and pro-apoptotic Bax showed
expression at 48 h and later (Fig. 9D). These results
demonstrate that cell cycle arrest markers (p15, p21, and
p27) are expressed early, the apoptotc markers (caspases 3
and 9, cleaved caspase 3) appear late confirming the earlier
Fig. 6. MES cells undergo TGFβ3-induced cell cycle arrest: MES cells grown in culture were treated with Aphidicolin (6 μM) for 16 h, which blocks DNA synthesis to
synchronize all MES cells at G1 phase (A). Once synchronized, MES cells were released from the block for 30 min, treated with TGFβ3 (5 ng/mL) added every 24 h
for 3 days, collected every 12 h of treatment, fixed with 70% ethanol (−20 °C), and FACSArray was done to evaluate cell cycle status. MES cells treated with TGFβ3
failed to advance to the next phases (S, G2, and M) and remained stagnant at G1. MES cells began to die and showed apoptosis as early as 24 h gradually reaching to
23% by 72 h without undergoing any cell cycle progression (B–F). In contrast, TGFβ3 untreated cells (control) twice progress through all phases of cell cycle (bottom
panel, G–L).
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apoptosis is late.
TGFβ3 generates two types of DNA fragmentation during
apoptosis
DNA fragmentation is an essential feature of apoptosis. But
the size of the DNA fragments can indicate whether the cell
death is caspase-dependent or not. We found that DNA
collected from TGFβ3 treated and untreated MES cells showedboth high (Fig. 10A) and low (Fig. 10C) molecular weight DNA
fragmentation in response to TGFβ3. Large size DNA
fragmentation (at 60 h, Fig. 10A) precedes the oligo
fragmentations pattern (72 h, Fig. 10C). Moreover, the extent
of DNA fragmentation is dose-dependent with TGFβ3
concentration (Figs. 10B, D). It is noteworthy that caspase-
dependent apoptosis generates LMW or oligo DNA fragments
whereas HMW DNA fragmentation is the result of caspase-
independent apoptosis (Bahi et al., 2006). These results
demonstrated that both caspase-dependent and caspase-
Fig. 7. TGFβ3 promotes MES cell to undergo apoptosis: MES cells grown in culture to 80% confluency were treated with TGFβ3. Nucleic acid dyes, C12-resazurin at
488 nm, and Sytox Red at 633 nm excitation show “Live” (P2) and “dead” (P1) cells, respectively. The figures show cell cycle arrested cells in pink (P4) and debris in
blue (P3). Within 12 h of TGFβ3 treatment, MES cells began to cease proliferating and undergo cell cycle arrest (P4) and the number of cell cycle arrested MES cells
continued to increase over time. Dead cells (P1) began to appear at 60 h of treatment and by 72 h, the number of “dead cells” reached nearly 33% of the total MES cells
with the remaining being “dying” cells. Untreated control cells (bottom panel), in contrast, remain live and viable (P2) as late as 72 h.
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induced by TGFβ3.
Translocation of caspase-independent apoptotic protein,
apoptotic inducing factor (AIF) into the MES cell nucleus by
TGFβ3
The mitochondrial protein AIF is an important executor of
cell death when translocated into the nucleus (Ekert and Vaux,
2005). Nuclear localization of AIF protein is a crucial
evidence to support functional caspase-independent apoptosis.
Our results showed that in response to TGFβ3 signaling, AIF
expression was limited to the cytoplasm of the MES cellsearly from 12 to 36 h and gradually showed reduced
cytoplasmic expression post 36 h. As cytoplasmic AIF protein
translocated into the nucleus, AIF expression showed
increased expression by 72 h in the nucleus by which stage
there were no or limited cytoplasmic AIF expression (Fig.
11A). Similarly, to identify the exact localization of AIF
within the cellular compartments, we demonstrated by
immunofluoroscene staining that AIF showed punctuate
mitochondrial expression by 24 h when cells were still
adhered (Fig. 11B, i) and even when MES cells began to
acquire migratory phenotype (Fig. 11B, ii). AIF expression
was diffused throughout the cytoplasm as well as in the
nucleus by 60 h of TGFβ3 treatment (Fig. 11B, iii). By 72 h,
Fig. 8. Apoptosis during MES disintegration: mouse palates from 17 dpc
embryos showed TUNEL positive cells in the developing palates. Double
immunofluorescences labeled TUNEL-FITC positive apoptotic cells were
present at the remnants of epithelial cells of the oral-palatine triangular regions
in near confluent palate (A, arrow). Rhodamine-conjugated E-cadherin antibody
was used to demarcate MES for accurate localization of the apoptotic cells.
Biotin/Streptavidin-HRP/DAB labeled TUNEL positive remaining apoptotic
MES cells were seen in the naso-palatine triangle (B). In MES cell culture,
TUNEL positive cells (Biotin/Streptavidin-HRP/DAB labeled) are only seen
72 h after TGFβ3 (5 ng/mL) treatment (D, arrow). No TUNEL positive cells
were seen in the untreated cells (C). MES cells were counter stained with H&E
for detailed morphology (C, D).
Fig. 9. Cell cycle arrest and apoptosis markers induced by TGFβ3: upon TGFβ3
treatment, protein expression of the cell cycle arrest markers p15, p21, and p27
gradually increased from 12 h to strong expression at 72 h with no cell
proliferation marker, PCNA expression (A) Caspases 9 and 3 showed gradually
increased expression from 36 to 72 h (B). In response to TGFβ3, MES cells
showed higher expression cleaved caspase 3 (17 and 19 kDa) at 60 and 72 h
compared to earlier time points (C). Anti-apoptotic BCL-2 and pro-apoptotic
Bax protein expression were inversely proportional. BCL-2 showed high
expression at 24 h of TGFβ3 treatment but gradually decreased. Bax on the
contrary showed very limited expression until 48 h with increased expression at
72 h (D). All untreated control (UN) experiments were done using the same
method as treated but the results shown are from 48 h as this is the time point
when all proteins are expressed mostly (A–D).
202 S. Ahmed et al. / Developmental Biology 309 (2007) 193–207most of the AIF was nuclear with no or limited cytoplasmic or
mitochondrial expression (Figs. 11B, iv).
Discussion
Although cleft palate is not life-threatening, functions
such as feeding, digestion, speech, middle-ear ventilation,
hearing, and respiration are disrupted due to distorted facial/
dental development. Consequently, cleft palate can lead to
considerable emotional, psychosocial, and learning problems.
TGFβ signaling contributes to development from gastrulation
to the completion of organogenesis (Boyer et al., 1999; Cui
and Shuler, 2000; Dudas and Kaartinen, 2005; Wakefield et
al., 2001) including palate development (Ferguson, 1988;
Fitzpatrick et al., 1990). Population-based candidate-gene
studies identified TGFβ3 as a candidate gene for human
non-syndromal cleft palate (Jugessur and Murray, 2005;
Mitchell et al., 2001; Murray and Schutte, 2004; Vieira et al.,
2003). Treatment of mouse palates with TGFβ3 antisense
oligos prevents palate development (Taya et al., 1999), and
most significantly, palates fail to develop in TGFβ3 null
mice (Martinez-Alvarez et al., 2000; Proetzel et al., 1995)
resulting in cleft palate. Cell migration and apoptosis are
highly conserved and fundamental processes that govern
morphogenesis (Hay, 1995; Vaux and Korsmeyer, 1999) andrecent studies have shown that TGFβ3 causes cell migration
or apoptosis as mechanisms of MES disintegration resulting
in confluent palate. We also found that apoptosis does play a
role in generating complete and successful palatal confluency
(Fig. 1F). While in vivo and in vitro evidence over-
whelmingly suggests the essential role of TGFβ3 in palatal
MES disintegration, how these epithelial cells respond to
TGFβ3 signaling and undergo cellular changes is in most
part unknown and remained to be investigated.
Our research combines our interests in palate development
and TGFβ-mediated cell migration and apoptosis to study the
role of TGFβ signaling in the disintegration of palatal MES
epithelium, a necessary step in palate development. Early studies
aimed at understanding howMES cells respond to TGFβ signals
were hampered by the limitations of an in vivo system. We have
now developed an MES cell culture system to facilitate studies
Fig. 10. MES cells undergo DNA fragmentation during apoptosis: MES cells in culture undergo both High Molecular Weight (HMW), −47 kbp (A), and Low
Molecular Weight (LMW), 100–700 bp (C). DNA fragmentation in response to TGFβ3 that occurs in a time-dependent manner at 60 and 72 h, respectively. And they
are also dose sensitive as higher concentrations of exogenous TGFβ3 induce a higher degree of fragmentation (B, D). All untreated control (UN) experiments were
done using the same method as treated but without TGFβ3 addition and the results from only 72 h are shown in the figures.
203S. Ahmed et al. / Developmental Biology 309 (2007) 193–207of the signaling mechanisms that drive palatal development.
Here, we demonstrate three distinctly different, yet chronologi-
cal MES cellular events—cell cycle arrest, cell migration, and
apoptosis that contribute to the complete palatal confluency in
response to TGFβ3 signaling. Although apoptosis follows cell
migration, these two events are independent and the cell cycle
arrest precedes both migration and apoptosis (Figs. 3E–H and
Figs. 5K, L). These findings are essential for a better under-
standing of the mechanism of palate development and to
potentially preventing clefting. However, it will be intriguing to
explore what controls the morphogenetic decision made byMES
cells as they switch from cessation of cell cycle to convergent
migratory phenotype to apoptosis.
TGFβ3 induces palatal MES cell cycle arrest
TGFβ has multiple roles including being a potent growth
inhibitor of epithelial cells and has been associated with effects
on G1 phase cyclins, cyclin-dependent kinases (CDKs), and
CDK inhibitors (Pardali et al., 2005; Takahashi et al., 2004;
Vega et al., 2004) and induces a growth inhibitory response via
p21 and p15 (Matsuyama et al., 2003). The cessation of cellcycle is a key regulator of signals that has effects on multiple
cell processes and usually precedes cell migration and
apoptosis (Boehm and Nabel, 2001; Bonneton et al., 1999).
A recent study by Donovan et al. (2002) used mouse mammary
epithelial cells to show that cyclin D1, CDK4, and cyclin A
were down-regulated and that the cell cycle inhibitors p15, p21,
and p27 were up-regulated by TGFβ treatment. As described
very recently by Moreno-Bueno et al. (2006) that other than
repressing E-cadherin, several transcription factors induced by
TGFβ may have multiple roles and simultaneously induce cell
cycle arrest by activating p21CIP1 and p18INK4 (Locascio et al.,
2002), cells programmed for migration and/or apoptosis may
undergo cell cycle arrest. Before replicating DNA, cells enter
the G1 phase and interpret a massive number of signals that
influence cell division and cell fate. Mistakes in this process
can lead to severe developmental anomaly; therefore, cell cycle
arrest is a beneficial regulatory method to avoid congenital
deformity.
Our results demonstrate that MES cells undergo cell cycle
arrest shortly after TGFβ3 treatment as shown by FACArray
(Figs. 6A–F) and cell cycle arrest marker proteins, p15, p21,
and p27, are also expressed at the same time (Fig. 9A). These
Fig. 11. Apoptotic inducing factor, AIF protein expression, and its nuclear
localization: in response to TGFβ3 signaling, AIF protein expression remained
cytoplasmic in the MES cells in the first 36 h of TGFβ3 treatment (A, lanes 2, 3,
and 4) and gradually the protein translocated into the nucleus showing low
expression of AIF protein with the nucleus beginning at 36 h (lane 4) and
expression gradually increased (lanes 4 and 5) and reached a peak by 60 h (A,
lanes 6 and 7). Similarly, exact localization of AIF protein expression was
confirmed by immunofluoroscene and in accord with immunoblot results,
immunofluoroscene results also showed punctate mitochondrial AIF expression
at 24 (B, panel i) and 48 h (B, panel ii). AIF protein gradually diffused in the
cytoplasm translocated into the nucleus (60 h, B, panel iii) and eventually was
completely nuclear by 72-h (B, panel iv) in the MES cells recognized by
fluorescein-conjugated anti-AIF monoclonal antibody. Each scale bar value, as
stated, represents the size and magnification of the image.
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effect of TGFβ3 in the MES cells. Cells undergoing either
transformation or apoptosis need to halt cell cycle progres-
sion to prepare cells to undergo for such changes. Apoptotic
cells will have no chance to migrate, therefore it is logical for
MES to migrate first followed by apoptosis by two mutually
exclusive TGFβ3 signaling mechanisms as it has been shown
in murine hepatocytes and in other epithelial cells (Yang et
al., 2006a). Thus it is likely that TGFβ induces growth arrest
before cell migration and apoptosis (Coquelle et al., 2006).
Since induction of cell cycle arrest by TGFβ3 precedes cell
migration and apoptosis, it is likely that cell cycle arrest
might be a prerequisite for both cell migration and apoptosis
in the MES cells.
Cell migration is facilitated by loss of E-cadherin
In order to acquire motility and migration, epithelial cells
need to lose cell–cell adhesion. Here we show that TGFβ3
represses MES cell–cell adhesion protein and E-cadherin
expression (Fig. 4B). Loss of E-cadherin by TGFβ3
facilitates MES cell migration as they express migratory
proteins such as Vimentin, Fibronectin, and α-SMA (Figs.
4C–F). Additionally, we demonstrated that increasing E-
cadherin by retroviral infection, we can inhibit MES cell
migration and motility (Figs. 5A–H, L). Therefore, in accord
with our previous study (Nawshad et al., 2007), our current
results support the notions that loss of E-cadherin is a
prerequisite for MES migration.Palatal MES apoptosis by TGFβ3
Two mutually exclusive events, cell migration and apoptosis,
are known to be brought about by TGFβ signaling (Yang et al.,
2006b). However, controversies still remain and two major
models have been proposed for seam degeneration: migration
(Hay, 1995; Jin andDing, 2006; Kaartinen et al., 1997; Kang and
Svoboda, 2005; Lagamba et al., 2005; Lavrin and Hay, 2000;
Nawshad andHay, 2003; Pungchanchaikul et al., 2005; Shuler et
al., 1992; Sun et al., 2000a,b; Takahara et al., 2004; Takigawa
and Shiota, 2004) or apoptosis (Cuervo and Covarrubias, 2004;
Dudas et al., 2006, 2007; Taniguchi et al., 1995; Vaziri Sani et
al., 2005; Xu et al., 2006). But all agree that both aspects of
palatogenesis are induced by TGFβ3. Our results showed that
both migration and apoptosis are required to complete palatal
confluence.
Whenever feasible, it is important to relate palatogenesis
with that of the genes of apoptotic machinery with knockout
murine model. Very recently, convincing results, using a Cre-
Loxp-based genetic labeling system, where the expression of
Cre recombinase was driven by a cytokeratin 14 (K14) pro-
moter (Vasioukhin and Fuchs, 2001) and where R26R reporter
locus was specifically activated and irreversibly labeled in the
MES epithelium, showed apoptosis as the only mechanism of
MES disintegration (Vaziri Sani et al., 2005; Xu et al., 2006).
Using a similar technique, there have been contradictory
results; Jin and Ding (2006) showed only epithelial–
mesenchymal transformation or EMT as the only way for
MES disintegration. Thus the results show that either
migration (Jin and Ding, 2006) or apoptosis (Vaziri Sani et
al., 2005; Xu et al., 2006) (not both) is the mechanism of
MES disintegration. To find out whether apoptosis is
functionally required for seam degeneration in vivo, Jin and
Ding (2006) showed that Apaf1 deficient mice, in which
caspases 9 and 3 are inactive, exhibit normal palate. These
results contradict an earlier finding showing the lack of palatal
shelves adherens (Honarpour et al., 2000) and absence of
MES disintegration (Cecconi et al., 1998) in Apaf-1 knockout
mice. Nevertheless, apoptosis can still take place via Apaf-1-
independent manner (Susin et al., 2000) as the cells deficient
in these molecules can still die (Green, 2005). Knockouts for
genes of the apoptotic pathways have also been problematic.
It is, however, noteworthy that some of the knockout models
can demonstrate a surprisingly high degree of phenotypic
variability among individual mouse lines and penetrance of
the phenotype in a mixed-background colony could well be
due to the presence of additional modifier loci (Doetschman,
1999).
Vaux and Korsmeyer (1999) argue that the pathways for
physiological program cell deaths occur during development
may not necessarily the same for those in pathological
conditions and well could be independent of caspases. More-
over, mutations of caspases 9 and 3 caused perinatal lethality
and the only organ to be abnormal is the brain (Matalova et al.,
2006; Setkova et al., 2007). It raises the possibility that during
palate development, apoptosis still might occur independent of
caspases. One of the candidate gene known is the Apoptosis
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apoptosis in a caspase-independent manner upon translocation
into the nucleus (Hansen and Nagley, 2003). Arnoult et al.
(2002) showed that inhibition of caspases can still activate AIF
to cause apoptosis. AIF is expressed in most of the murine
developing organs (Joza et al., 2001) concomitant with the
timing of palatogenesis. In addition, TGFβ is capable of
activating both AIF (Dormann and Bauer, 1998) and several
caspases (Schuster and Krieglstein, 2002). AIF knockouts have
extensive cell death in embryos (Brown et al., 2006).
Part of this discrepancy may stem from dual pathways for
apoptosis, one being caspase-dependent by Apaf-1 and other
being caspase-independent by AIF (Hansen and Nagley,
2003). Therefore, characterizing apoptosis in MES with Apaf-
1 null mice (Jin and Ding, 2006) alone is insufficient
(Cecconi et al., 1998; Green, 2005). In the view of conflicting
results (Jin and Ding, 2006; Vaziri Sani et al., 2005; Xu et al.,
2006), we investigated further the mechanisms of apoptosis in
response to TGFβ3 during MES disintegration.
Our in vivo and in vitro results imply that TGFβ3-induced
apoptosis is an integral but late fate of MES disintegration
(Figs. 6E, F, 7, 8, 9B, C, and 10). It is reasonable to have
apoptotic induction late when MES cells complete migration
in the developing palate. Moreover, the late increased
expressions of caspase 9 and 3 (Fig. 9B), cleaved caspase 3
(Fig. 9C), and pro-apoptotic Bax (Fig. 9D) match closely with
the in vivo advent of apoptosis (Fig. 8). Such late induction
of apoptosis has also been implied with FACSArray and
DNA fragmentation results (Figs. 6, 7, and 10) and the
apoptotic changes that MES cells undergo at 60 h in response
to TGFβ3. DNA degradation, which is a hallmark of
apoptosis, can be achieved by both caspase-dependent and
caspase-independent (AIF-induced) intrinsic pathways gener-
ating two different size of DNA fragments, high molecular
weight (HMW) ∼50 kb (AIF-dependent) and low molecular
weight (LMW), oligo (caspase-dependent). Both mechanisms
initiate and bifurcate from mitochondria, upstream of Apaf-1,
to release lethal proteins. While overwhelming evidence
supports TGFβ3-induced apoptosis as a late event of MES
disappearance, the mechanisms of apoptosis are yet to be
fully understood. Interestingly; we found a late induction
(60 h) of significant HMW (∼50 kb) DNA fragments, which
is a sign of caspase-independent apoptosis (Bahi et al., 2006)
as well LMW (oligo) fragment in response to TGFβ3 in a
time- and dose-dependent manner (Fig. 10). In response to
apoptotic stimulation, concurrent to cytochrome c for caspase
activation, AIF is also released from mitochondria and
translocates into the nucleus due to its nuclear localization
signal. AIF is devoid of any nuclease activity (Cande et al.,
2002) so once in the nucleus, it randomly binds to the DNA
(Vahsen et al., 2006), reconfigures chromatin structure, and
recruits Topoisomerase II to induce ∼50 kb DNA fragments.
AIF is implicated strongly during embryonic apoptosis (Joza
et al., 2001).
Our data show that TGFβ3-induced caspase-dependent and
caspase-independent mechanisms of apoptosis are functional in
MES cells. AIF is a mitochondrial protein known to translocateto the nucleus during caspase-independent apoptosis where it
participates in the high molecular DNA fragmentations.
Moreover, to validate the role of AIF in MES cells, we
examined the cellular localization of AIF in MES cells at
various stages of TGFβ3 treatment by immunofluorescent
staining with anti-AIF antibody. We showed that AIF protein
expression shifts from cytoplasm to nucleus in response to
TGFβ3 (Figs. 11A, B). Our results also demonstrated that in
response to TGFβ3, AIF protein expression gradually
translocates from the mitochondria (punctuate mitochondrial
localization) to the cytoplasm (diffuse cytoplasmic localiza-
tion) and eventually into the nucleus (DNA bound localization)
(Fig. 11B). AIF is a sensitive and specific marker for the
identification of the early stage of apoptosis that has HMW
DNA fragmentations (Zhao et al., 2003). These results suggest
that AIF participates in the DNA fragmentation during MES
apoptosis. Therefore, we predict that induction of apoptosis in
the MES cells by TGFβ3 is both caspase-dependent and
caspase-independent. Further research might shed light into the
rationale and mechanisms of dual apoptotic methods in palatal
MES cells. We showed that following MES cell migration,
TGFβ3 exerts its effects by activating pro-apoptotic factors that
induce both caspase-dependent and -independent apoptosis to
complete palatal confluence.
During the process of palate development, the MES is
formed upon adhesion of the palatal shelves. The sedentary
seam epithelial cells then undergo significant phenotypical
changes from migratory to apoptotic cells during palatogen-
esis. TGFβ3 signals are interpreted by complex intracellular
circuits, resulting in coordinated changes in gene expression
and cellular morphogenesis to induce cell migration and
death. Our data demonstrates that TGFβ3 induces cell cycle
arrest, cell migration, and apoptosis in primary MES and
these integrated processes transform the palatal seam epithelia
into a single confluent palatal mesenchymal structure. Our
results suggest that apoptosis is independent of migration.
Moreover, MES cells also undergo cell cycle arrest prior to
cell migration. We showed an in vitro model of chronological
events that take places during palate development by TGFβ3
signaling in the context of palatal MES disintegration. While
TGFβ3 can signal via multiple pathways to activate many
transcription factors to generate several cellular outcomes,
such as cell cycle arrest, migration, and apoptosis, we predict
that timing, level and length of signals, and activation of
downstream molecules are responsible for such diverse
phonotypical effects in the same cell type by same activator
(TGFβ3). In the future, we will determine the genes,
transcription factors, and cellular changes that are necessary
for palatogenesis and address how TGFβ3 signaling selec-
tively activates what is required for migration and apoptosis
and represses which are not in the formation of confluent
palate.
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